“Poorly differentiated” refers to cancer cells that have more abnormalities and look less like normal cancer cells. Poorly differentiated thyroid cancer is uncommon, accounting for fewer than 5% of ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Papillary and follicular thyroid cancers are considered well-differentiated cancers. Papillary thyroid cancer is the most prevalent type of thyroid cancer--with over 50,000 new cases per year in the ...

T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety ...

Therefore, what are the realistic expectations for the state of thyroid cancer therapeutics in the coming years? Vandetanib is the only FDA-approved therapy currently available for the treatment ...

such as anaplastic thyroid cancer or poorly differentiated thyroid cancer, present more abruptly, often as a large lump that ...

Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival ...

Targeted therapy for thyroid cancer with BRAF and RET inhibitors has progressed to Phase II clinical trials with first results on the therapeutic response pending. Schematic representation of ...

Researchers from the Endocrine Tumors group at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with ...

Get Instant Summarized Text (Gist) Radioiodine therapy after surgery increases relative survival rates in differentiated thyroid cancer patients across all risk groups. The greatest benefit is ...